Src Mutation Induces Acquired Lapatinib Resistance in ERBB2-Amplified Human Gastroesophageal Adenocarcinoma Models

ERBB2-directed therapy is now a routine component of therapy for ERBB2-amplified metastatic gastroesophageal adenocarcinomas. However, there is little knowledge of the mechanisms by which these tumors develop acquired resistance to ERBB2 inhibition. To investigate this question we sought to characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yong Sang, Kim, Jihun, Pectasides, Eirini, Fox, Cameron, Hong, Seung-Woo, Ma, Qiuping, Wong, Gabrielle S., Peng, Shouyong, Stachler, Matthew D., Thorner, Aaron R., Van Hummelen, Paul, Bass, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211679/
https://www.ncbi.nlm.nih.gov/pubmed/25350844
http://dx.doi.org/10.1371/journal.pone.0109440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211679/
https://www.ncbi.nlm.nih.gov/pubmed/25350844
http://dx.doi.org/10.1371/journal.pone.0109440

Ejemplares similares